JP2023514347A5 - - Google Patents

Info

Publication number
JP2023514347A5
JP2023514347A5 JP2022549518A JP2022549518A JP2023514347A5 JP 2023514347 A5 JP2023514347 A5 JP 2023514347A5 JP 2022549518 A JP2022549518 A JP 2022549518A JP 2022549518 A JP2022549518 A JP 2022549518A JP 2023514347 A5 JP2023514347 A5 JP 2023514347A5
Authority
JP
Japan
Application number
JP2022549518A
Other languages
Japanese (ja)
Other versions
JPWO2021168128A5 (https=
JP2023514347A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/018599 external-priority patent/WO2021168128A1/en
Publication of JP2023514347A publication Critical patent/JP2023514347A/ja
Publication of JPWO2021168128A5 publication Critical patent/JPWO2021168128A5/ja
Publication of JP2023514347A5 publication Critical patent/JP2023514347A5/ja
Pending legal-status Critical Current

Links

JP2022549518A 2020-02-18 2021-02-18 同種移植のための組成物及び方法 Pending JP2023514347A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202062978141P 2020-02-18 2020-02-18
US62/978,141 2020-02-18
US202063062845P 2020-08-07 2020-08-07
US63/062,845 2020-08-07
PCT/US2021/018599 WO2021168128A1 (en) 2020-02-18 2021-02-18 Compositions and methods for allogeneic transplantation

Publications (3)

Publication Number Publication Date
JP2023514347A JP2023514347A (ja) 2023-04-05
JPWO2021168128A5 JPWO2021168128A5 (https=) 2024-02-26
JP2023514347A5 true JP2023514347A5 (https=) 2024-02-26

Family

ID=77391794

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022549518A Pending JP2023514347A (ja) 2020-02-18 2021-02-18 同種移植のための組成物及び方法

Country Status (10)

Country Link
US (1) US20230390412A1 (https=)
EP (1) EP4107188A4 (https=)
JP (1) JP2023514347A (https=)
KR (1) KR20220154676A (https=)
CN (1) CN115397444A (https=)
AU (1) AU2021224663A1 (https=)
CA (1) CA3168039A1 (https=)
IL (1) IL295653A (https=)
MX (1) MX2022009885A (https=)
WO (1) WO2021168128A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4051711A4 (en) * 2019-11-01 2024-02-21 Magenta Therapeutics, Inc. ANTI-CD45 ANTIBODIES AND THEIR CONJUGATES
US12496303B2 (en) * 2020-10-19 2025-12-16 Washington University Conditioning agents for use in allogeneic hematopoietic stem cell transplantation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3174902B1 (en) * 2014-08-01 2019-04-17 Institut National de la Sante et de la Recherche Medicale (INSERM) An anti-cd45rc antibody for use as drug
HK1249534A1 (zh) * 2015-04-06 2018-11-02 哈佛大学校长及研究员协会 用於非清髓性预处理的组合物和方法
CN109641051A (zh) * 2016-06-17 2019-04-16 美真达治疗公司 用于耗尽细胞的组合物和方法
EP3595683A1 (en) * 2017-03-15 2020-01-22 Orca Biosystems, Inc. Compositions and methods for hematopoietic stem cell transplants

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
JP2022530089A5 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
JP2023514347A5 (https=)
JP2022535527A5 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR112023016292A2 (https=)
BR112023011610A2 (https=)
BR112023011539A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)